20/20 GeneSystems offering is now closed and is no longer accepting investments.
INVEST IN 20/20 GENESYSTEMS TODAY!
Diagnostic Testing for COVID-19 & Cancer
$1,320,413.60 Raised
ABOUT
HEADQUARTERS
9430 Key West Ave. Suite 100
Rockville, MD 20850
WEBSITE
View Site
20/20 GeneSystems (“20/20”) is a digital diagnostics company with the core mission of reducing cancer mortality in the U.S. and around the world through early detection.
TERMS
20/20 GeneSystems
Overview
PRICE PER SHARE
$4.40
DEADLINE
May 16, 2020
VALUATION
$38.5M
AMOUNT RAISED
$1,320,413.60
Breakdown
MIN INVESTMENT
$501.60
MAX INVESTMENT
$2,000,002.40
MIN NUMBER OF SHARES OFFERED
2,250
OFFERING TYPE
Equity
ASSET TYPE
COMMON
SHARES OFFERED
Common Stock
MAX NUMBER OF SHARES OFFERED
3,340,908
Maximum Number of Shares Offered subject to adjustment for bonus shares
Company | : | [Company Legal Name] |
Corporate Address | : | [Company Address], [CITY NAME], [STATE LOCATION] [CITY ZIP] |
Offering Minimum | : | $10,000.00 |
Offering Maximum | : | $14,699,999.60 |
Minimum Investment Amount(per investor) | : | $501.60 |
Terms
Offering Type | : | Equity |
Security Name | : | Common Stock |
Minimum Number of Shares Offered | : | 10,000 |
Maximum Number of Shares Offered | : | 14,700,000 |
Price per Share | : | $1.00 |
Pre-Money Valuation | : | $38,499,375.00 |
ALL UPDATES
05.15.20
Last chance to invest! Campaign ends tonight
Thank you again to all of our investors! Our StartEngine campaign ends tonight so make sure to get in now!
20/20 Management Team
This Reg A+ offering is made available through StartEngine Primary, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. For more information about this offering, please view 20/20’s offering circular and risks associated with this offering.
03.24.20
Over $500k raised!
Over $500,000 raised! Thank you to our early adopters and community for believing in our mission.
02.15.20
20/20's OneTest for Firefighters featured on local TV newscast in suburban Atlanta
Earlier this week a local newscast outside of Atlanta Georgia featured a story about how the Clayton County Fire Department has been using 20/20's OneTest to help their members screen for cancer. The 3 minute story can be viewed here:
Studies by the U.S. Centers for Disease Control have proven that firefighters have a statistically significant increase in cancer incidence and death for more than a dozen cancer types (especially those of the digestive tract.) Moreover, studies among Korean firefighters have demonstrated that annual check ups that measure several of the tumor markersin OneTest reduce death rates.
20/20's founder is a former volunteer firefighter and a co-inventor of the company's patented BioCheck kits for screening suspicious powders. See www.BioCheckInfo.com Those kits have been popular with fire departments worldwide for many years.
02.07.20
20/20 presents at IBM AI Symposium this week
Earlier this week 20/20 was one of only nine start-ups invited to present at Symposium on AI for Biomedical Imaging held at IBM Research's San Jose campus. Participants at this event included R&D leaders from IBM Research, IBM Watson Health, and leading medical schools such as Stanford and Penn. 20/20's CEO Jonathan Cohen presented the company's vision for improving early cancer detection by building machine learning algorithms that combine in-vitro (lab tests) and in-vivo (imaging) diagnostics. For example, algorithms that integrate the levels of biomarkers like CA-125 and AFP (both part of our OneTest) with ultrasound should substantially boost the accuracy of ovarian and liver cancer detection respectively. At the Silicon Valley symposium we made contacts with industry and academic leaders in the field that we expect will help 20/20 execute on that vision over the coming years.
REWARDS
$2,500
$2,500
For those who invest $2,500, two transferable multi-cancer or lung tests
$10,000
$10,000
For those who invest $10,000, six transferable multi-cancer or lung tests.
$75,000
$75,000
For those who invest $75,000, twenty transferable multi-cancer or lung tests
$100,000
$100,000
For those who invest $100,000, a lifetime of annual cancer screenings for a spousal pair
$200,000
$200,000
For those who invest $200,000, all the above perks plus all-expenses-paid trip (airfare & lodging) for 1 to travel to Taiwan for a 2-day state-of-the-art platinum level medical checkup, including OneTest + full battery of tests for all body systems
$250,000
$250,000
For those who invest $250,000, all of the above live campaign perks for two individuals
$500,000
$500,000
For those who invest $500,000, all of the above live campaign perks for four individuals
JOIN THE DISCUSSION
0/2500
HOW INVESTING WORKS
Cancel anytime before 48 hours before a rolling close or the offering end date.
WHY STARTENGINE?
REWARDS
We want you to succeed and get the most out of your money by offering rewards and memberships!
SECURE
Your info is your info. We take pride in keeping it that way!
DIVERSE INVESTMENTS
Invest in over 200 start-ups and collectibles!
With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.
With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000, are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, he/she is limited to investing 10% of the greater of the two amounts.
At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.
Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.
StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market, or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.
For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.
For Regulation A+, StartEngine allows for a four-hour cancelation period. Once the four-hour window has passed, it is up to each company to set their own cancelation policy. You may find the company’s cancelation policy in the company’s offering circular.
Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.
Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to get sent back to the account associated with the investment.
Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.
